Worldwide Sleep Aids Industry to 2025 - Featuring DeVilbiss Healthcare, SleepMed & Pfizer Among Others

Dublin, IRELAND


Dublin, Sept. 03, 2020 (GLOBE NEWSWIRE) -- The "Global Sleep Aids Market: Consumer Behavior Analysis by Countries, Buying Pattern Analysis, Demographics, Trends Analysis, Survey Findings and Results, Leading Companies and Their Market Strategies" report has been added to ResearchAndMarkets.com's offering.

The global sleep aids market was valued at USD 71.04 billion in 2018 and it is expected to grow with a CAGR of 7% over the forecast period of 2019-2025.

The rise in the incidences of sleeping disorders such as insomnia, sleep apnea, and restless leg syndrome is the major driver for the global sleep aids market. It is mainly due to underlying diseases, psychological disorders, or changes in environmental conditions. Moreover, the rise in the geriatric population is also contributing to the growing demand for sleep aids. The population aging over 65 years and above is majorly affected by sleeping disorders and is the main consumers of sleep aid products. In addition, factors such as the growing amount of mental stress due to hectic life, unhealthy habits such as smoking and drinking, and lack of physical exercise are further augmenting the growth of the global sleep aids market.

The survey conducted by The author found that majority of people across the world take advice from the physicians before using an OTC medication. Many individuals suffering from a sleep disorder, particularly the younger adults are aware of their condition and its affect on their mental and physical health. Such people often tend to visit doctors or physicians for professional advice and for the treatment of sleep disorder. Moreover, physicians are the professionals who are experts in the field of healthcare and they can suggest an appropriate treatment for sleeping disorders than anyone else. This, in turn, encourages people to consult physicians before buying and using any kind of sleep aids.

The United States, Germany, and the UK among Top Markets for Sleep Aids

According to the findings in the report, the countries in North America and Europe along with China are the top markets for sleep aids. Europe and North America together make more than 65% of the total sales of sleep aids in the world. The US is the leading country in terms of sales in the global sleep aids market followed by Germany and the UK. The rise in the incidences of sleeping disorders and the growing geriatric population are the major drivers for the sale of OTC drugs in western countries. Moreover, the higher population base and the availability of various products in the market are the major factors contributing to the growth of the Chinese sleep aids market. On the other hand, the sale of sleep aids in developing countries such as India is anticipated to grow rapidly. Factors including growing awareness regarding sleeping disorders and a number of government initiatives to improve public healthcare are majorly influencing the sale of sleep aids in developing countries.

North America Generated Highest Revenue from Sleep Aids

Based on the geographical regions, North America generated the highest revenue in the global sleep aids market. A large pool of population suffering from sleeping disorders such as insomnia and sleep apnea is the major driving factor for the North American sleep aids market. Fast-paced life due to the busy schedule and an unhealthy lifestyle leads to the growing incidences of sleep disorder. Moreover, the rise in the prevalence of chronic disorders such as obesity, diabetes, and cardiac disorders, which may cause sleep disorders, is also supporting the growth of the market in North America. Furthermore, the Asia Pacific region is projected to grow with the fastest rate owing to the growing awareness regarding sleep disorders and their treatment. The improving healthcare sector in the developing nations in the Asia Pacific is offering favorable business opportunities to the major players in the sleep aids market.

Key Topics Covered:

1. Introduction

2. Executive Summary

3. Market Overview & Competitiveness
3.1. Introduction
3.2. DRO Analysis
3.2.1. Drivers
3.2.1.1. Growing prevalence of sleeping disorder
3.2.1.2. Rise in the geriatric population
3.2.1.3. Increase in mental stress due to hectic life
3.2.2. Restraints
3.2.2.1. Side effects due to abuse
3.2.3. Opportunities
3.2.3.1. Technological advancements in the sleep aids
3.3. Analysis of COVID-19 impact on the Sleep Aids Market
3.3.1. Impact of COVID-19 on the Sales of Sleep Aids Market 2020-2026
3.3.2. Impact of COVID-19 on the Sleep Aids Market by Region
3.3.2.1. North America
3.3.2.2. Europe
3.3.2.3. Asia Pacific
3.3.2.4. RoW
3.4. Porter's Five Forces Analysis
3.5. Value Chain Analysis of Sleep Aids Market
3.6. Product Placement and Positioning Matrices
3.6.1. Growth Share Matrix
3.6.2. Product Placement Matrix
3.6.3. Product Life Cycle Analysis

4. Company Profiles and Competitive Landscape
4.1. Competitive Landscape and Top Recent Developments
4.2. Leading Company Profiles and Their Products in the Global Sleep Aids
4.2.1. Teva Pharmaceutical Industries Ltd.
4.2.1.1. Overview
4.2.1.2. Company Snapshot
4.2.1.3. Financial Snapshot
4.2.1.4. Product Portfolio
4.2.1.5. Recent Developments
4.2.2. DeVilbiss Healthcare LLC
4.2.2.1. Overview
4.2.2.2. Company Snapshot
4.2.2.3. Financial Snapshot
4.2.2.4. Product Portfolio
4.2.2.5. Recent Developments
4.2.3. SleepMed Inc.
4.2.3.1. Overview
4.2.3.2. Company Snapshot
4.2.3.3. Financial Snapshot
4.2.3.4. Product Portfolio
4.2.3.5. Recent Developments
4.2.4. Pfizer Inc.
4.2.4.1. Overview
4.2.4.2. Company Snapshot
4.2.4.3. Financial Snapshot
4.2.4.4. Product Portfolio
4.2.4.5. Recent Developments
4.2.5. Cadwell Laboratories Inc.
4.2.5.1. Overview
4.2.5.2. Company Snapshot
4.2.5.3. Financial Snapshot
4.2.5.4. Product Portfolio
4.2.5.5. Recent Developments
4.2.6. GlaxoSmithKline Plc
4.2.6.1. Overview
4.2.6.2. Company Snapshot
4.2.6.3. Financial Snapshot
4.2.6.4. Product Portfolio
4.2.6.5. Recent Developments
4.2.7. Sanofi SA.
4.2.7.1. Overview
4.2.7.2. Company Snapshot
4.2.7.3. Financial Snapshot
4.2.7.4. Product Portfolio
4.2.7.5. Recent Developments
4.2.8. Merck & Co., Inc.
4.2.8.1. Overview
4.2.8.2. Company Snapshot
4.2.8.3. Financial Snapshot
4.2.8.4. Product Portfolio
4.2.8.5. Recent Developments
4.2.9. SleepMed Incorporated
4.2.9.1. Overview
4.2.9.2. Company Snapshot
4.2.9.3. Financial Snapshot
4.2.9.4. Product Portfolio
4.2.9.5. Recent Developments
4.2.10. Natus Medical Incorporated
4.2.10.1. Overview
4.2.10.2. Company Snapshot
4.2.10.3. Financial Snapshot
4.2.10.4. Product Portfolio
4.2.10.5. Recent Developments

5. Global Sleep Aids Market, by Segmentation
5.1. Global Sleep Aids Market, by Product
5.1.1. Mattress & Pillows
5.1.2. Sleep Laboratories
5.1.3. Medications
5.1.4. Sleep Apnea Devices
5.2. Global Sleep Aids Market, by Sleep Disorder
5.2.1. Insomnia
5.2.2. Sleep Apnea
5.2.3. Restless Leg Syndrome
5.2.4. Narcolepsy
5.2.5. Sleep Walking
5.2.6. Other Sleep Disorders

6. Global Sleep Aids Market, by Region
6.1. Overview
6.2. North America Sleep Aids Market
6.3. Europe Sleep Aids Market
6.4. Asia-Pacific Sleep Aids Market
6.5. RoW Sleep Aids Market

For more information about this report visit https://www.researchandmarkets.com/r/9bvzz3

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

 

Contact Data